Botanical species · safety record

Huperzia saururus

The EFSA Compendium of Botanicals holds 16 constituent measurements for Huperzia saururus. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Huperzia saururus (Lam.) Trevis.

16Constituent measurements
0Safety records
5Cited sources
0Licensed products (Canada)

Also recorded as

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

  • Sauroxine4
  • Quinolizidine alkaloids3
  • Clavolonine2
  • Lycodine2
  • Lycopodine2
  • Alkaloids1
  • Huperzine a1
  • Sesquiterpene alkaloids1

Plant parts

  • Aerial part of plants8
  • Unspecified6
  • Leaves2

Preparations

  • Solvent extraction8

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
AlkaloidsLeavesSolvent extractionColorimetry, Spectroscopy (Spectrometry) and PhotometryResolve DOI
ClavolonineAerial part of plantsSolvent extractionGC-MSResolve DOI
LycodineAerial part of plantsSolvent extractionGC-MSResolve DOI
LycopodineAerial part of plantsSolvent extractionGC-MSResolve DOI
Quinolizidine alkaloidsAerial part of plantsSolvent extractionGC-MSResolve DOI
Quinolizidine alkaloidsAerial part of plantsSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
SauroxineLeavesSolvent extractionColorimetry, Spectroscopy (Spectrometry) and PhotometryResolve DOI
SauroxineAerial part of plantsSolvent extractionGC-MSResolve DOI
SauroxineAerial part of plantsGC-MS/MSResolve DOI
Sesquiterpene alkaloidsAerial part of plantsGC-MS/MSResolve DOI
ClavolonineUnspecifiedUnspecifiedNo resolvable identifier
Huperzine aUnspecifiedUnspecifiedNo resolvable identifier
LycodineUnspecifiedUnspecifiedNo resolvable identifier
LycopodineUnspecifiedUnspecifiedNo resolvable identifier
Quinolizidine alkaloidsUnspecifiedUnspecifiedNo resolvable identifier
SauroxineUnspecifiedUnspecifiedNo resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Deulofeu, V., De Langhe, J. Studies on Argentine Plants. III. Alkaloids from Lycopodium Saururus1. Journal of the american chemical society, 1942, vol. 64, no. 4, p. 968-969. DOI
  2. Ortega, MG., Agnese, AM., Cabrera, JL. Anticholinesterase activity in an alkaloid extract of Hyperzia saururus. Phytomedicine, 2004, vol. 11, no. 6, p. 539-543. DOI
  3. Ortega, MG., Agnese, AM., Cabrera, JL. Sauroine - a novel Lycopodium alkaloid from Huperzia saururus. Tetrahedron letters, 2004, vol. 45, no. 38, p. 7003-7005. DOI
  4. Ortega, M. G., Vallejo, M. G., Agnese, A. M., Cabrera, J. L. Huperzia saururus: Anticholinesterase Activity and Action on Memory and Learning . Drug plants iii, 2010, vol. 29, p. 345-362.
  5. Cifuente, Diego A., Vallejo, Mariana G., Ortega, Maria G., Cabrera, Jose L., Martin, Victor S., Tonn, Carlos E., Agnese, Alicia M., Ardanaz, Carlos E. Mass spectrometry studies of lycodine-type Lycopodium alkaloids: sauroxine and N-demethylsauroxine . Rapid communications in mass spectrometry, 2014, vol. 28, no. 24, p. 2690-2694. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue